Owner Mylan Laboratories, Inc.

Inventors Bottini, Peter Bruce; Davis, Eric; O'Donnell, John

Agent Freehills

Pub. Number AU-B-2005249514

PCT Pub. Number WO2005/117858

Priority 11/141,235 31.05.05 US; 60/577,423 04.06.04 US

Filing date 1 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 7 April 2011

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/353 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system